Vyant Bio
Business Services · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2370 State Rte 70 W Ste 310, Cherry Hill...Phone Number
(201) 479-1357Website
www.vyantbio.comRevenue
<$5 MillionStock Symbol
VYNTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vyant Bio
Vyant Bio's dynamic drug discovery engine is powered by a convergence of innovative bioengineering technologies and industry-leading data science. Vyant Bio was founded in 1999 and is headquartered in New Jersey.Explore more
Vyant Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vyant Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Vyant Bio has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Vyant Bio launches new products
Vyant Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Vyant Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Vyant Bio
Website visits: Recent activity has been detected on your website
Check out if Vyant Bio is spiking on competitors!
Click to see if Vyant Bio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Vyant Bio has new funding data
Recommended Actions
Reach out to Masked Content who joined Vyant Bio as Masked Content
Find 3 more new buyers
Compare Similar Companies to Vyant Bio
Compare insights from companies similar to Vyant Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vyant Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vyant Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vyant Bio.
Vyant Bio financials insights
Gather financial insights about Vyant Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$6M
Vyant Bio Tech Stack
A closer look at the technologies used by Vyant Bio
See more technologies
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
Lateral Move
Executive Move
Left Company
Executive Move
Left Company
Executive Move
Vyant Bio News & Media
Vyant Bio Provides Update on Winddown Activities
CHERRY HILL, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) is providing an update to shareholders regarding its winddown activities pursuant to its Plan of Liquidation and Dissolution following the sale of substantially all of its assets. Vyant Bio’s Board of Directors currently anticipates that it will file a Certificate of Dissolution with the State of Delaware in late December 2023, after which the Company’s common stockVyant Bio Announces Stockholder Approval of Plan of Dissolution
CHERRY HILL, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) is announcing the results of its special meeting of stockholders on November 1, 2023 (the “Special Meeting”).Vyant Bio Announces Completion of StemoniX Asset Sale
CHERRY HILL, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) announced that it has completed the sale of all or substantially all of the assets of the Company (the “Sale”) pursuant to an Asset Purchase Agreement dated July 13, 2023.Vyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of Stockholders
CHERRY HILL, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) announced that its special meeting of stockholders on October 19, 2023 (the “Special Meeting”) was reconvened resulting in the approval of the sale of all or substantially all of the assets of the Company.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Vyant Bio
Sign Up For FreeTo access detailed company insights
Vyant Bio's dynamic drug discovery engine is powered by a convergence of innovative bioengineering technologies and industry-leading data science. Vyant Bio was founded in 1999 and is headquartered in New Jersey.... Read More
